AJCN Yamada Bee Farm Grant for Honeybee Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiler, H.
Right arrow Articles by Ogborn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiler, H.
Right arrow Articles by Ogborn, M.
Agricola
Right arrow Articles by Weiler, H.
Right arrow Articles by Ogborn, M.
American Journal of Clinical Nutrition, Vol. 79, No. 6, 1186S-1189S, June 2004
© 2004 American Society for Clinical Nutrition


THE ROLE OF CONJUGATED LINOLEIC ACID IN HUMAN HEALTH

Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats1,2,3,4

Hope Weiler, Susan Austin, Shirley Fitzpatrick-Wong, Evan Nitschmann, Neda Bankovic-Calic, Rebecca Mollard, Harold Aukema and Malcolm Ogborn

1 From the Department of Human Nutritional Sciences (HW, SA, SF-W, RM, HA, and MO) and the Department Pediatrics and Child Health (HW, EN, NB-C, HA, and MO), University of Manitoba, Winnipeg, Manitoba, Canada

ABSTRACT

Background: Feeding conjugated linoleic acid (CLA) is reported to reduce prostaglandin E2 synthesis, which is required for parathyroid hormone (PTH) release.

Objective: This study was undertaken to determine whether CLA would suppress hyperparathyroidism and the resulting high-turnover bone disease in a rat model of polycystic kidney disease (PKD).

Design: Outcome measurements were conducted after 8 wk of feeding diets supplemented with and without CLA (1% of dietary fat) to Han:SPRD-cy male rats (n = 52). PTH, bone formation, and resorption were assessed in addition to femur bone mass with use of dual-energy X-ray absorptiometry.

Results: CLA feeding resulted in attenuation of PTH concentrations in both PKD-affected and nonaffected rats (by 60%) but did not significantly alter bone formation and resorption.

Conclusion: Reduction in PTH may open possibilities for CLA as an adjunctive therapy in secondary hyperparathyroidism.

Key Words: Polycystic kidney disease • bone metabolism • parathyroid hormone • conjugated linoleic acid • Han:SPRD-cy rats




This article has been cited by other articles:


Home page
Exp Biol MedHome page
I. Platt, L. G. Rao, and A. El-Sohemy
Isomer-Specific Effects of Conjugated Linoleic Acid on Mineralized Bone Nodule Formation from Human Osteoblast-LikeCells
Exp Biol Med, February 1, 2007; 232(2): 246 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition